We are proud to announce the latest development of our company, KYLYS. Our patent has been granted in the US for our unique technology: HA Pearls! We are so excited...
More InformationKYLYS was granted an Innosuisse project to develop HA Pearls product towards novel therapeutic application. This project is in collaboration with the University of...
More InformationKYLYS is pleased to announce that its main patent application filed under the Patent Cooperation Treaty (PCT) convention recently entered the national phases. This is...
More InformationWe are very proud to have been selected by the BioInnovation Day 2018 organization to present our project HA Pearls. The 8th edition of BioInnovation Day took place on...
More InformationProud to announce that our startup KYLYS won the 2nd prize in the Global Healthcare Innovation Academy (GHIA) in Hong-Kong for its new approach to treat...
More InformationKYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible...
More InformationWe have presented our technology to a prestigious international meeting: the 44th Annual Meeting & Exposition of the Controlled Release Society in Boston,...
More InformationWe have presented our technology to the most important world hyaluronan conference in Cleveland, Ohio, United States.
More InformationWe have presented our experience “from researcher to entrepreneur” to a packed audience at the Centre Médical Universitaire on Tuesday, 2nd of May 2017,...
More InformationEvery year since 2007 the University Hospital of Geneva (HUG), in partnership with the Geneva Faculty of Medicine, has organized Innovation Days where a...
More InformationBiomolecules now, for your future